Therapeutics, Inc. (Nasdaq: ANIK) today announced that it has
entered into a new agreement with Medline
Industries, Inc. to commercialize the Company’s advanced wound care
product - Hyalomatrix ® , in the United States on an exclusive
basis through 2019.
for Anika Therapeutics Announces U.S. Commercialization Partnership for Hyalomatrix® with Wound Care Leader Medline Industries, Inc. investment picks